Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Zimmer Biomet Holdings (ZBH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 24,549,600
  • Shares Outstanding, K 204,580
  • Annual Sales, $ 7,933 M
  • Annual Income, $ -379,200 K
  • 60-Month Beta 1.23
  • Price/Sales 3.09
  • Price/Cash Flow 6.81
  • Price/Book 2.17

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 27 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 1.86
  • Number of Estimates 15
  • High Estimate 1.94
  • Low Estimate 1.83
  • Prior Year 1.91
  • Growth Rate Est. (year over year) -2.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
118.02 +1.68%
on 04/18/19
129.71 -7.49%
on 04/09/19
-5.32 (-4.25%)
since 03/18/19
3-Month
103.17 +16.31%
on 01/22/19
129.71 -7.49%
on 04/09/19
+14.66 (+13.92%)
since 01/18/19
52-Week
96.99 +23.72%
on 12/24/18
134.55 -10.81%
on 09/21/18
+9.92 (+9.01%)
since 04/18/18

Most Recent Stories

More News
Earnings Preview: Zimmer Biomet (ZBH) Q1 Earnings Expected to Decline

Zimmer (ZBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ZBH : 120.00 (+0.26%)
Look for Shares of Zimmer Biomet Ho to Potentially Rebound after Yesterday's 3.26% Sell Off

Zimmer Biomet Ho (NYSE:ZBH) traded in a range yesterday that spanned from a low of $121.29 to a high of $125.84. Yesterday, the shares fell 3.3%, which took the trading range below the 3-day low of $125.27...

ZBH : 120.00 (+0.26%)
Aesthetic Devices Market to Grow at a CAGR of 10% During 2018- 2024

New York, April 15, 2019: The scope of the report includes a detailed study of Global with the reasons given for variations in the growth of the industry in certain regions.

VRX.TO : 30.80 (-3.33%)
ZBH : 120.00 (+0.26%)
ZLTQ : 56.48 (unch)
AGN : 140.31 (+0.20%)
CYNO : 66.15 (+0.23%)
ELOS : 11.00 (unch)
MMM : 218.88 (+0.57%)
SIEN : 7.52 (-1.83%)
NSRGF : 94.5700 (+0.07%)
Shares of Zimmer Biomet Ho Rank the Highest in Terms of Relative Performance in the Health Care Equipment Industry (ZBH , VAR , MASI , HRC , RMD )

We looked at the Health Care Equipment industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

ZBH : 120.00 (+0.26%)
VAR : 130.78 (-0.67%)
MASI : 122.47 (+0.15%)
Aesthetic Devices Market is Expected to Touch a Value of US$ 18.50 Billion by 2024

New York, April 05, 2019: The scope of the report includes a detailed study of Global with the reasons given for variations in the growth of the industry in certain regions.

VRX.TO : 30.80 (-3.33%)
ZBH : 120.00 (+0.26%)
ZLTQ : 56.48 (unch)
AGN : 140.31 (+0.20%)
CYNO : 66.15 (+0.23%)
ELOS : 11.00 (unch)
MMM : 218.88 (+0.57%)
SIEN : 7.52 (-1.83%)
NSRGF : 94.5700 (+0.07%)
Investor Expectations to Drive Momentum within The Hain Celestial Group, Allegheny Technologies, The Hanover Insurance Group, Zimmer Biomet, Corbus Pharmaceuticals, and Preformed Line Products -- Discovering Underlying Factors of Influence

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of The Hain Celestial Group, Inc....

ZBH : 120.00 (+0.26%)
THG : 117.03 (+0.52%)
CRBP : 7.04 (+1.59%)
ATI : 25.72 (-1.27%)
PLPC : 56.87 (+0.46%)
HAIN : 22.38 (-0.53%)
Aesthetic Devices Market to Grow US$ 18.50 Billion by 2024

New York, March 28, 2019: Aesthetic devices are employed in rehabilitative and body sculpting surgeries majorly concentrating on increasing the quotient of mode. There are alternative edges to usage of...

VRX.TO : 30.80 (-3.33%)
ZBH : 120.00 (+0.26%)
ZLTQ : 56.48 (unch)
AGN : 140.31 (+0.20%)
CYNO : 66.15 (+0.23%)
ELOS : 11.00 (unch)
MMM : 218.88 (+0.57%)
SIEN : 7.52 (-1.83%)
NSRGF : 94.5700 (+0.07%)
Uptrend Call Working As Zimmer Biomet Ho Stock Rises 20.2% (ZBH)

SmarTrend identified an Uptrend for Zimmer Biomet Ho (NYSE:ZBH) on January 17th, 2019 at $105.61. In approximately 2 months, Zimmer Biomet Ho has returned 20.18% as of today's recent price of $126.92....

ZBH : 120.00 (+0.26%)
Aesthetic Devices Market to Grow US$ 18.50 Billion by 2024

New York, March 27, 2019: Aesthetic devices are employed in rehabilitative and body sculpting surgeries majorly concentrating on increasing the quotient of mode. There are alternative edges to usage of...

VRX.TO : 30.80 (-3.33%)
ZBH : 120.00 (+0.26%)
ZLTQ : 56.48 (unch)
AGN : 140.31 (+0.20%)
CYNO : 66.15 (+0.23%)
ELOS : 11.00 (unch)
MMM : 218.88 (+0.57%)
SIEN : 7.52 (-1.83%)
NSRGF : 94.5700 (+0.07%)
Zimmer Biomet's FDA 510(k) Nod Widens Robotic Offerings

With the FDA nod, Zimmer Biomet (ZBH) attains the status of being the first company to boast the 510(k) clearance for Brain, Spine and Knee offerings on a single robotic platform globally.

ZBH : 120.00 (+0.26%)
HOLX : 43.40 (-0.07%)
ITGR : 70.89 (-0.85%)
VEEV : 127.83 (-0.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade ZBH with:

Business Summary

Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related...

See More

Key Turning Points

2nd Resistance Point 122.60
1st Resistance Point 121.30
Last Price 120.00
1st Support Level 118.36
2nd Support Level 116.72

See More

52-Week High 134.55
Fibonacci 61.8% 120.20
Last Price 120.00
Fibonacci 50% 115.77
Fibonacci 38.2% 111.34
52-Week Low 96.99

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar